Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64


RORγt limits the amount of the cytokine receptor γc through the prosurvival factor Bcl-xL in developing thymocytes.

Ligons DL, Hwang S, Waickman AT, Park JY, Luckey MA, Park JH.

Sci Signal. 2018 Aug 28;11(545). pii: eaam8939. doi: 10.1126/scisignal.aam8939.


IL-7-dependent STAT1 activation limits homeostatic CD4+ T cell expansion.

Le Saout C, Luckey MA, Villarino AV, Smith M, Hasley RB, Myers TG, Imamichi H, Park JH, O'Shea JJ, Lane HC, Catalfamo M.

JCI Insight. 2017 Nov 16;2(22). pii: 96228. doi: 10.1172/jci.insight.96228. eCollection 2017 Nov 16.


On the Origin of Covalent Bonding in Heavy Actinides.

Kelley MP, Su J, Urban M, Luckey M, Batista ER, Yang P, Shafer JC.

J Am Chem Soc. 2017 Jul 26;139(29):9901-9908. doi: 10.1021/jacs.7b03251. Epub 2017 Jul 12.


Worldwide prevalence and incidence of osteoporotic vertebral fractures.

Ballane G, Cauley JA, Luckey MM, El-Hajj Fuleihan G.

Osteoporos Int. 2017 May;28(5):1531-1542. doi: 10.1007/s00198-017-3909-3. Epub 2017 Feb 6. Review.


Soluble γc cytokine receptor suppresses IL-15 signaling and impairs iNKT cell development in the thymus.

Park JY, Jo Y, Ko E, Luckey MA, Park YK, Park SH, Park JH, Hong C.

Sci Rep. 2016 Nov 11;6:36962. doi: 10.1038/srep36962.


Characterization of berkelium(III) dipicolinate and borate compounds in solution and the solid state.

Silver MA, Cary SK, Johnson JA, Baumbach RE, Arico AA, Luckey M, Urban M, Wang JC, Polinski MJ, Chemey A, Liu G, Chen KW, Van Cleve SM, Marsh ML, Eaton TM, van de Burgt LJ, Gray AL, Hobart DE, Hanson K, Maron L, Gendron F, Autschbach J, Speldrich M, Kögerler P, Yang P, Braley J, Albrecht-Schmitt TE.

Science. 2016 Aug 26;353(6302). pii: aaf3762. doi: 10.1126/science.aaf3762.


Activated T cells secrete an alternatively spliced form of common γ-chain that inhibits cytokine signaling and exacerbates inflammation.

Hong C, Luckey MA, Ligons DL, Waickman AT, Park JY, Kim GY, Keller HR, Etzensperger R, Tai X, Lazarevic V, Feigenbaum L, Catalfamo M, Walsh ST, Park JH.

Immunity. 2014 Jun 19;40(6):910-23. doi: 10.1016/j.immuni.2014.04.020. Epub 2014 Jun 5.


The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling.

Luckey MA, Kimura MY, Waickman AT, Feigenbaum L, Singer A, Park JH.

Nat Immunol. 2014 Jul;15(7):638-45. doi: 10.1038/ni.2917. Epub 2014 Jun 1.


Secular trends in hip fractures worldwide: opposing trends East versus West.

Ballane G, Cauley JA, Luckey MM, Fuleihan Gel-H.

J Bone Miner Res. 2014 Aug;29(8):1745-55. doi: 10.1002/jbmr.2218.


Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis.

Le Saout C, Hasley RB, Imamichi H, Tcheung L, Hu Z, Luckey MA, Park JH, Durum SK, Smith M, Rupert AW, Sneller MC, Lane HC, Catalfamo M.

PLoS Pathog. 2014 Mar 6;10(3):e1003976. doi: 10.1371/journal.ppat.1003976. eCollection 2014 Mar.


Interleukin-6 expands homeostatic space for peripheral T cells.

Hong C, Nam AS, Keller HR, Ligons DL, Park JY, Yoon HW, Park JJ, Luckey MA, Park JH.

Cytokine. 2013 Nov;64(2):532-40. doi: 10.1016/j.cyto.2013.08.001. Epub 2013 Aug 26.


Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus.

Tinsley KW, Hong C, Luckey MA, Park JY, Kim GY, Yoon HW, Keller HR, Sacks AJ, Feigenbaum L, Park JH.

Blood. 2013 Oct 3;122(14):2358-68. doi: 10.1182/blood-2012-12-472076. Epub 2013 Aug 1.


Metabolic sensor AMPK directly phosphorylates RAG1 protein and regulates V(D)J recombination.

Um JH, Brown AL, Singh SK, Chen Y, Gucek M, Lee BS, Luckey MA, Kim MK, Park JH, Sleckman BP, Gellert M, Chung JH.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9873-8. doi: 10.1073/pnas.1307928110. Epub 2013 May 28.


Pim1 permits generation and survival of CD4+ T cells in the absence of γc cytokine receptor signaling.

Linowes BA, Ligons DL, Nam AS, Hong C, Keller HR, Tai X, Luckey MA, Park JH.

Eur J Immunol. 2013 Sep;43(9):2283-94. doi: 10.1002/eji.201242686. Epub 2013 Jun 21.


γc Cytokine signaling: graduate school in thymic education.

Luckey MA, Park JH.

Blood. 2013 Jan 3;121(1):4-6. doi: 10.1182/blood-2012-10-461525. No abstract available.


The DNA damage- and transcription-associated protein paxip1 controls thymocyte development and emigration.

Callen E, Faryabi RB, Luckey M, Hao B, Daniel JA, Yang W, Sun HW, Dressler G, Peng W, Chi H, Ge K, Krangel MS, Park JH, Nussenzweig A.

Immunity. 2012 Dec 14;37(6):971-85. doi: 10.1016/j.immuni.2012.10.007. Epub 2012 Nov 15.


CD8 lineage-specific regulation of interleukin-7 receptor expression by the transcriptional repressor Gfi1.

Ligons DL, Tuncer C, Linowes BA, Akcay IM, Kurtulus S, Deniz E, Atasever Arslan B, Cevik SI, Keller HR, Luckey MA, Feigenbaum L, Möröy T, Ersahin T, Atalay R, Erman B, Park JH.

J Biol Chem. 2012 Oct 5;287(41):34386-99. doi: 10.1074/jbc.M112.378687. Epub 2012 Aug 3.


An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis.

Kim GY, Ligons DL, Hong C, Luckey MA, Keller HR, Tai X, Lucas PJ, Gress RE, Park JH.

J Immunol. 2012 Jun 15;188(12):5859-66. doi: 10.4049/jimmunol.1102328. Epub 2012 May 16.


Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development.

Hong C, Luckey MA, Park JH.

Semin Immunol. 2012 Jun;24(3):151-8. doi: 10.1016/j.smim.2012.02.002. Epub 2012 Mar 14. Review.


Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Cauley JA, El-Hajj Fuleihan G, Arabi A, Fujiwara S, Ragi-Eis S, Calderon A, Chionh SB, Chen Z, Curtis JR, Danielson ME, Hanley DA, Kroger H, Kung AW, Lesnyak O, Nieves J, Pluskiewicz W, El Rassi R, Silverman S, Schott AM, Rizzoli R, Luckey M; FRAX(®) Position Conference Members.

J Clin Densitom. 2011 Jul-Sep;14(3):240-62. doi: 10.1016/j.jocd.2011.05.015.


FRAX® International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference.

Cauley JA, El-Hajj Fuleihan G, Luckey MM; FRAX(®) Position Development Conference Members.

J Clin Densitom. 2011 Jul-Sep;14(3):237-9. doi: 10.1016/j.jocd.2011.05.016.


Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.

Hans DB, Kanis JA, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Cooper C, Dawson-Hughes B, El-Hajj Fuleihan G, Leslie WD, Lewiecki EM, Luckey MM, McCloskey EV, Papapoulos SE, Poiana C, Rizzoli R; FRAX(®) Position Development Conference Members.

J Clin Densitom. 2011 Jul-Sep;14(3):171-80. doi: 10.1016/j.jocd.2011.05.007.


Interpretation and use of FRAX in clinical practice.

Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV; Task Force of the FRAX Initiative.

Osteoporos Int. 2011 Sep;22(9):2395-411. doi: 10.1007/s00198-011-1713-z. Epub 2011 Jul 21. Review.


Folding studies of purified LamB protein, the maltoporin from the Escherichia coli outer membrane: trimer dissociation can be separated from unfolding.

Baldwin V, Bhatia M, Luckey M.

Biochim Biophys Acta. 2011 Sep;1808(9):2206-13. doi: 10.1016/j.bbamem.2011.05.013. Epub 2011 May 24.


Ethnic difference of clinical vertebral fracture risk.

Bow CH, Cheung E, Cheung CL, Xiao SM, Loong C, Soong C, Tan KC, Luckey MM, Cauley JA, Fujiwara S, Kung AW.

Osteoporos Int. 2012 Mar;23(3):879-85. doi: 10.1007/s00198-011-1627-9. Epub 2011 Apr 2.


American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM; AACE Osteoporosis Task Force.

Endocr Pract. 2010 Nov-Dec;16 Suppl 3:1-37. No abstract available.


American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM.

Endocr Pract. 2010 Nov-Dec;16(6):1016-9. No abstract available.


Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.

Miller PD, Delmas PD, Lindsay R, Watts NB, Luckey M, Adachi J, Saag K, Greenspan SL, Seeman E, Boonen S, Meeves S, Lang TF, Bilezikian JP; Open-label Study to Determine How Prior Therapy with Alendronate or Risedronate in Postmenopausal Women with Osteoporosis Influences the Clinical Effectiveness of Teriparatide Investigators.

J Clin Endocrinol Metab. 2008 Oct;93(10):3785-93. doi: 10.1210/jc.2008-0353. Epub 2008 Aug 5.


Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007.

Lewiecki EM, Bilezikian JP, Cooper C, Hochberg MC, Luckey MM, Maricic M, Miller PD.

J Clin Densitom. 2008 Apr-Jun;11(2):313-24. doi: 10.1016/j.jocd.2007.12.017. Epub 2008 Feb 14.


Bisphosphonates and osteonecrosis of the jaw.

Watts NB, Harris ST, McClung MR, Bilezikian JP, Greenspan SL, Luckey MM.

Ann Intern Med. 2006 Nov 21;145(10):791-2; author reply 792. No abstract available.


Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry.

Baim S, Wilson CR, Lewiecki EM, Luckey MM, Downs RW Jr, Lentle BC.

J Clin Densitom. 2005 Winter;8(4):371-8. Review.


Daily and cyclic parathyroid hormone in women receiving alendronate.

Cosman F, Nieves J, Zion M, Woelfert L, Luckey M, Lindsay R.

N Engl J Med. 2005 Aug 11;353(6):566-75.


Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.

Miller PD, McClung MR, Macovei L, Stakkestad JA, Luckey M, Bonvoisin B, Reginster JY, Recker RR, Hughes C, Lewiecki EM, Felsenberg D, Delmas PD, Kendler DL, Bolognese MA, Mairon N, Cooper C.

J Bone Miner Res. 2005 Aug;20(8):1315-22. Epub 2005 Mar 14.


Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis.

Luckey M, Kagan R, Greenspan S, Bone H, Kiel RD, Simon J, Sackarowitz J, Palmisano J, Chen E, Petruschke RA, de Papp AE.

Menopause. 2004 Jul-Aug;11(4):405-15.


Alendronate in the prevention of osteoporosis: 7-year follow-up.

Sambrook PN, Rodriguez JP, Wasnich RD, Luckey MM, Kaur A, Meng L, Lombardi A.

Osteoporos Int. 2004 Jun;15(6):483-8. Epub 2004 Feb 13.


American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.

Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC Jr, Kleerekoper M, Lindsay R, Luckey MM, McClung MR, Nankin HR, Petak SM, Recker RR; AACE Osteoporosis Task Force.

Endocr Pract. 2003 Nov-Dec;9(6):544-64. No abstract available. Erratum in: Endocr Pract. multiple author names added. Endocr Pract. 2004 Jan-Feb;10(1):90.


Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosis.

Luckey MM, Gilchrist N, Bone HG, Davie MW, de Villiers TJ, Wu M, Daifotis AG, Santora AC, Orloff JJ.

Obstet Gynecol. 2003 Apr;101(4):711-21.


Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women.

Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M.

J Clin Endocrinol Metab. 2002 Oct;87(10):4431-7.


Osteoporosis. Recommended guidelines and New Jersey legislation.

Shapses SA, Luckey MM, Levine JP, Timins JK, Mackenzie GM.

N J Med. 2000 Nov;97(11):53-7. Review.


A peptide from the adenovirus fiber shaft forms amyloid-type fibrils.

Luckey M, Hernandez J, Arlaud G, Forsyth VT, Ruigrok RW, Mitraki A.

FEBS Lett. 2000 Feb 18;468(1):23-7.


Resistance to bone resorbing effects of PTH in black women.

Cosman F, Morgan DC, Nieves JW, Shen V, Luckey MM, Dempster DW, Lindsay R, Parisien M.

J Bone Miner Res. 1997 Jun;12(6):958-66.


Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women.

Parisien M, Cosman F, Morgan D, Schnitzer M, Liang X, Nieves J, Forese L, Luckey M, Meier D, Shen V, Lindsay R, Dempster DW.

J Bone Miner Res. 1997 Jun;12(6):948-57.


IAC/cELISA detection of monensin elimination from chicken tissues, following oral therapeutic dosing.

Godfrey MA, Luckey MF, Kwasowski P.

Food Addit Contam. 1997 Apr;14(3):281-6.


Bone density in Type 1 Gaucher disease.

Pastores GM, Wallenstein S, Desnick RJ, Luckey MM.

J Bone Miner Res. 1996 Nov;11(11):1801-7.


Structural and functional characterization of OmpF porin mutants selected for larger pore size. II. Functional characterization.

Saint N, Lou KL, Widmer C, Luckey M, Schirmer T, Rosenbusch JP.

J Biol Chem. 1996 Aug 23;271(34):20676-80.


A prospective study of bone loss in African-American and white women--a clinical research center study.

Luckey MM, Wallenstein S, Lapinski R, Meier DE.

J Clin Endocrinol Metab. 1996 Aug;81(8):2948-56.


Racial differences in pre- and postmenopausal bone homeostasis: association with bone density.

Meier DE, Luckey MM, Wallenstein S, Lapinski RH, Catherwood B.

J Bone Miner Res. 1992 Oct;7(10):1181-9.


Calcium, vitamin D, and parathyroid hormone status in young white and black women: association with racial differences in bone mass.

Meier DE, Luckey MM, Wallenstein S, Clemens TL, Orwoll ES, Waslien CI.

J Clin Endocrinol Metab. 1991 Mar;72(3):703-10.


Supplemental Content

Loading ...
Support Center